|
|
Article: Depression treatment shows promise for major depressive disorder.
- Article from:
- Health & Medicine Week
- Article date:
- December 22, 2003
CopyrightCOPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2003 DEC 22 - (NewsRx.com & NewsRx.net) -- There were no significant tolerability issues attributable to chronic vs. acute use of the investigational agent Cymbalta; patients who tolerated Cymbalta during the early period of the trial were likely to tolerate long-term dosing. Of the patients in the study, 520 remained on Cymbalta for at least 360 days, yielding approximately 808 patient-years of total exposure.
In addition, patients in the study who responded to treatment with Cymbalta had a high probability of achieving remission. Remission rates at 52 weeks in this study were close to response rates (81.8% and 89.1%, respectively), implying that patients who ...